Weight-loss drug frenzy powers Lilly for ninth straight annual rise
Shares of Eli Lilly LLY.N have risen nearly 40% this year - set for the ninth successive year of gains
The world's most valuable healthcare company joined the trillion dollar club last month
U.S.-listed stock of rival Novo Nordisk NOVOb.CO in comparison has declined 40% this year, set for its second year in red
Investors are focused on the potential approval and launch of LLY's oral GLP-1 drug orforglipron for 2026
Novo's Wegovy pill and LLY's orforglipron must drive accelerated demand to justify the willingness to lower pricing not only within government's Medicare and Medicaid programs, but also in the cash pay obesity market, brokerage Guggenheim said in a note earlier this month
Despite anticipated price changes, brokerage forecasts 20% overall sales growth to $76.8 billion in 2026 for Lilly, driven primarily by diabetes drug Mounjaro and Zepbound for obesity with incremental growth coming from launch of the pill
Shares of obesity drug giants Lilly and Novo
Related Articles
National Debt Bomb Ignited? Musk Warns U.S. Will Be 1000% Bankrupt Without AI
TradingKey - Tesla (TSLA) CEO Elon Musk recently issued another warning regarding the rapidly ballooning U.S. national debt. He stated clearly that without artificial intelligence and robotics, the United States will inevitably head toward fiscal bankruptcy.
Tesla Stock Outlook: Competing With Rivian, Robotaxi Potential, and 2026 Prospects
There is much conversation about the prospect of investing in Tesla (TSLA) as we move closer to 2026. The volatility of its share price in 2025 is leading many investors to consider if they should purchase shares of Tesla given the alternatives available in terms of electric vehicles (Rivian, etc.).
Why Sanae Takaichi Winning Japan’s Diet Election Led to a Surge in Japanese Stock Indices？
TradingKey - Reports indicate that the ruling coalition led by Japanese Prime Minister Sanae Takaichi has secured a single-party majority in the parliamentary elections held on Sunday (February 8). Following the news, the yen weakened slightly, while the Nikkei Index surpassed 57,000 for the first t
A Crash After a Surge: Why Silver Lost 40% in a Week?
TradingKey - Spot silver (XAGUSD) prices continue to decline. Silver plunged 20% on Thursday, breaking below $71 per ounce, with the sell-off intensifying on Friday as prices fell further below $64. Compared to the all-time high set on January 29, silver prices have retraced more than 40%, wiping out nearly all gains accumulated over the previous month.
